294 related articles for article (PubMed ID: 16330610)
21. [Ziprasidone. A new second-generation antipsychotic agent].
Lublin HK
Ugeskr Laeger; 2004 Mar; 166(14):1334-9. PubMed ID: 15101124
[No Abstract] [Full Text] [Related]
22. Inadvertent administration of intravenous ziprasidone leading to bradycardia and QT interval prolongation.
Bentley ML; Biscardi FH; Butcher C; Levitov A
Ann Pharmacother; 2008 Jun; 42(6):902-3. PubMed ID: 18477728
[No Abstract] [Full Text] [Related]
23. New onset of diabetes mellitus with ziprasidone: a case report.
Sánchez-Barranco P
J Clin Psychiatry; 2005 Feb; 66(2):268-9. PubMed ID: 15705019
[No Abstract] [Full Text] [Related]
24. Tolerability of ziprasidone: an expanding perspective.
Daniel DG
J Clin Psychiatry; 2003; 64 Suppl 19():40-9. PubMed ID: 14728089
[TBL] [Abstract][Full Text] [Related]
25. Activation induced by high-dose ziprasidone: a case report.
Kaushik S; Maccabee N; Kaushik S; Lindenmayer JP
J Clin Psychiatry; 2009 Sep; 70(9):1326-7. PubMed ID: 19818257
[No Abstract] [Full Text] [Related]
26. Effectiveness, safety, and tolerability of ziprasidone for treating schizophrenia patients undergoing usual care: a 12-month, open-label, flexible-dose, naturalistic observational trial.
Ratner Y; Gibel A; Yorkov V; Ritsner MS
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1401-9. PubMed ID: 17669574
[TBL] [Abstract][Full Text] [Related]
27. Ziprasidone-induced acute laryngeal dystonia.
Duggal HS
Prog Neuropsychopharmacol Biol Psychiatry; 2007 May; 31(4):970; author reply 971. PubMed ID: 17343967
[No Abstract] [Full Text] [Related]
28. Methodological concerns in a trial of ziprasidone and olanzapine.
Ross DE
Am J Psychiatry; 2005 Jul; 162(7):1391; author reply 1391-2. PubMed ID: 15994735
[No Abstract] [Full Text] [Related]
29. A 6-month prospective, observational, naturalistic, uncontrolled study to evaluate the effectiveness and tolerability of oral ziprasidone in patients with schizophrenia.
Arango C; Gómez-Beneyto M; Brenlla J; Gastó C; Sarramea-Crespo F; Chamorro L; Masramon X; Díez T;
Eur Neuropsychopharmacol; 2007; 17(6-7):456-63. PubMed ID: 17234389
[TBL] [Abstract][Full Text] [Related]
30. Ziprasidone hydrochloride.
Am J Health Syst Pharm; 2002 Jan; 59(1):28-9. PubMed ID: 11813463
[No Abstract] [Full Text] [Related]
31. Methodological concerns in a trial of ziprasidone and olanzapine.
Carnahan RM; Perry PJ
Am J Psychiatry; 2005 Jul; 162(7):1391; author reply 1391-2. PubMed ID: 15994736
[No Abstract] [Full Text] [Related]
32. An exploratory open-label trial of ziprasidone for the treatment of behavioral and psychological symptoms of dementia.
Rocha FL; Hara C; Ramos MG; Kascher GG; Santos MA; de Oliveira Lança G; Magalhães Scoralick F
Dement Geriatr Cogn Disord; 2006; 22(5-6):445-8. PubMed ID: 16983187
[TBL] [Abstract][Full Text] [Related]
33. Four-week, double-blind, placebo- and ziprasidone-controlled trial of iloperidone in patients with acute exacerbations of schizophrenia.
Cutler AJ; Kalali AH; Weiden PJ; Hamilton J; Wolfgang CD
J Clin Psychopharmacol; 2008 Apr; 28(2 Suppl 1):S20-8. PubMed ID: 18334909
[TBL] [Abstract][Full Text] [Related]
34. Urticaria and angio-oedema due to ziprasidone.
Akkaya C; Sarandol A; Aydogan K; Kirli S
J Psychopharmacol; 2007 Jul; 21(5):550-2. PubMed ID: 17446198
[TBL] [Abstract][Full Text] [Related]
35. Acute dystonia, akathisia, and parkinsonism induced by ziprasidone.
Praharaj SK; Jana AK; Sarkhel S; Sinha VK
Am J Ther; 2014; 21(2):e38-40. PubMed ID: 23698184
[TBL] [Abstract][Full Text] [Related]
36. Ziprasidone-related neuroleptic malignant syndrome in a patient with Parkinson's disease: a diagnostic challenge.
Gray NS
Hum Psychopharmacol; 2004 Apr; 19(3):205-7. PubMed ID: 15079855
[TBL] [Abstract][Full Text] [Related]
37. Possible serotonin syndrome with citalopram following cross-titration of clozapine to ziprasidone.
Kinzie E; Meltzer-Brody S
Gen Hosp Psychiatry; 2005; 27(3):223-4. PubMed ID: 15882772
[No Abstract] [Full Text] [Related]
38. Possible ziprasidone-induced mania.
Larson MF; Hauser A
J Am Acad Child Adolesc Psychiatry; 2003 Sep; 42(9):1012; discussion 1012-3. PubMed ID: 12964565
[No Abstract] [Full Text] [Related]
39. Intramuscular ziprasidone treatment of acute psychotic agitation in elderly patients with schizophrenia.
Barak Y; Mazeh D; Plopski I; Baruch Y
Am J Geriatr Psychiatry; 2006 Jul; 14(7):629-33. PubMed ID: 16816018
[TBL] [Abstract][Full Text] [Related]
40. Successful treatment of delusional disorder with low-dose aripiprazole.
Miyamoto S; Miyake N; Ogino S; Endo T; Yamaguchi N
Psychiatry Clin Neurosci; 2008 Jun; 62(3):369. PubMed ID: 18588606
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
